| Priority One Medical Equipment | |
| 330 Us 31 W By-pass, Ste 401, Bowling Green, Kentucky 42101 | |
| (270) 746-5745 |
| Name | Priority One Medical Equipment |
|---|---|
| Organization Name | Jl Webb Dme Llc |
| Location | 330 Us 31 W By-pass, Ste 401, Bowling Green, Kentucky 42101 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (270) 746-5745 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that the company's proposed research collaboration with the University of Massachusetts Medical School has been selected for Cooperative Research Matching Grant funding by the Massachusetts Life Sciences Center.
The introduction of a sugar tax, increasing the price of fizzy drinks and other products high in sugar content, has had only a limited, moderate effect in shifting people's dietary habits and behaviours, according to a new study.
Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' response to immunotherapy drugs. An increasingly promising focus of cancer research, the drugs are designed to disarm cancer cells' ability to avoid detection and destruction by the immune system.
The first investigational transplant of a genetically engineered, nonhuman kidney to a human body was recently completed at NYU Langone Health—marking a major step forward in potentially utilizing an alternative supply of organs for people facing life-threatening disease.
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new research suggesting that, on average, most women were willing to accept the risk of unnecessary follow-ups for an increased chance of detecting a cancer in screening.
› Verified 7 days ago
| NPI Number | 1063414571 |
| Organization Name | JL WEBB DME LLC |
| Doing Business As | PRIORITY 1 MEDICAL EQUIPMENT |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 330 31 W Bypass, Ste 401, Bowling Green, KY 42101 |
| Phone Number | 270-746-5745 |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that the company's proposed research collaboration with the University of Massachusetts Medical School has been selected for Cooperative Research Matching Grant funding by the Massachusetts Life Sciences Center.
The introduction of a sugar tax, increasing the price of fizzy drinks and other products high in sugar content, has had only a limited, moderate effect in shifting people's dietary habits and behaviours, according to a new study.
Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' response to immunotherapy drugs. An increasingly promising focus of cancer research, the drugs are designed to disarm cancer cells' ability to avoid detection and destruction by the immune system.
The first investigational transplant of a genetically engineered, nonhuman kidney to a human body was recently completed at NYU Langone Health—marking a major step forward in potentially utilizing an alternative supply of organs for people facing life-threatening disease.
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new research suggesting that, on average, most women were willing to accept the risk of unnecessary follow-ups for an increased chance of detecting a cancer in screening.
› Verified 7 days ago
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that the company's proposed research collaboration with the University of Massachusetts Medical School has been selected for Cooperative Research Matching Grant funding by the Massachusetts Life Sciences Center.
The introduction of a sugar tax, increasing the price of fizzy drinks and other products high in sugar content, has had only a limited, moderate effect in shifting people's dietary habits and behaviours, according to a new study.
Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' response to immunotherapy drugs. An increasingly promising focus of cancer research, the drugs are designed to disarm cancer cells' ability to avoid detection and destruction by the immune system.
The first investigational transplant of a genetically engineered, nonhuman kidney to a human body was recently completed at NYU Langone Health—marking a major step forward in potentially utilizing an alternative supply of organs for people facing life-threatening disease.
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new research suggesting that, on average, most women were willing to accept the risk of unnecessary follow-ups for an increased chance of detecting a cancer in screening.
› Verified 7 days ago
Medequip Type: Durable Medical Equipment & Medical Supplies Supplier Location: 825 2nd Ave East, Bowling Green, Kentucky 42101 Phone: (270) 780-2655 | |
Tomorrow's Woman Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1623 Scottsville Rd, Bowling Green, Kentucky 42104 Phone: (270) 781-5171 | |
Vision Source Of Bowling Green Type: Medicare Supplier Location: 335 New Towne Rd, Bowling Green, Kentucky 42103 Phone: (270) 842-0383 | |
C.d.s. #10 Pharmacy Llc Type: Long Term Care Pharmacy Location: 1308 Ashley Circle, Bowling Green, Kentucky 42104 Phone: (270) 781-5661 | |
Springhill Pharmacy Type: Pharmacy Location: 2305 Russellville Rd, Bowling Green, Kentucky 42101 Phone: (270) 796-3909 |